SaveWay Compounding Pharmacy Inc.

Form 483 issued June 22, 2017 · Newark, Delaware

Inspection
Jun 13 – Jun 22, 2017
Investigator
Anita R. Michael
Observations
1
Pages
1
FEI number
3006101483

In short: On June 22, 2017, FDA issued a Form 483 with 1 observation to SaveWay Compounding Pharmacy Inc. in Newark, Delaware (FEI 3006101483) after an inspection that ran Jun 13 – Jun 22, 2017. The investigator was Anita R. Michael. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

1 of 1 observations on this 483 concern facilities & equipment.

Facilities & equipment1

Most cited: 21 CFR 211.42(c)(10)(iv) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Aseptic processing areas are deficient regarding the system…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at SaveWay Compounding Pharmacy Inc.?

FDA listed 1 observation on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected SaveWay Compounding Pharmacy Inc.?

Anita R. Michael is named on this Form 483, for the inspection of Jun 13 – Jun 22, 2017. Each investigator has a profile showing what they cite most.

When was SaveWay Compounding Pharmacy Inc. inspected by FDA?

The inspection ran Jun 13 – Jun 22, 2017, and the Form 483 is dated June 22, 2017.

How do I get the full Form 483 for SaveWay Compounding Pharmacy Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free